Correlation Between Cognitive Function Impairment and Chronic Kidney Disease With a Low Glomerular Filtration Rate at Sanglah Hospital Denpasar

Anak Agung Ayu Putri Laksmidewi; Cok Istri Gangga Dewi Dewi; Yennny Kandarini

doi:10.3889/oamjms.2020.4691

Authors

Anak Agung Ayu Putri Laksmidewi Department of Neurology, Faculty of Medicine, Udayana University, Sanglah General Hospital, Bali, Indonesia
Cok Istri Gangga Dewi Dewi Department of Neurology, Faculty of Medicine, Udayana University, Sanglah General Hospital, Bali, Indonesia
Yennny Kandarini Department of Internal Medicine, Division of Nephrology/Hypertension, Faculty of Medicine, Udayana University, Sanglah General Hospital, Bali, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2020.4691

Keywords:

glomerular filtration rate, cognitive disorders, chronic kidney disease

Abstract

BACKGROUND: Chronic kidney disease is a condition of chronic kidney damage with abnormal structure and function of the kidneys that lasts more than 3 months, accompanied or not by a decrease in glomerular filtration rate. Organic kidney disease leaves accumulated organic waste that cannot be removed by the kidneys. Furthermore, several biochemical and metabolic mechanisms such as chronic inflammation and oxidative stress can cause executive disorders.

AIM: The aim of the study was to find out an increased risk of impaired cognitive function in patients with chronic kidney disease with a low glomerular filtration rate in Sanglah Hospital.

METHOD: This study uses a retrospective case–control analytic observational study design. We included all patients with chronic kidney disease in Sanglah Hospital in December 2017–January 2018. This study involved 46 subjects with chronic kidney disease who met eligibility criteria, classified as a case group with cognitive impairment and a control group without cognitive impairment.

RESULTS: Each decrease in glomerular filtration rate < 30 ml/min/173 m2 in patients with chronic renal failure correlates with an increased incidence of cognitive impairment of around 15–25%. The risk of chronic kidney disease patients with glomerular filtration rate < 30 ml/min/1.73 m2 decreased cognitive function 13 times compared to subjects with glomerular filtration rate > 30 ml/min/ 1.73 m2.

CONCLUSION: Low glomerular filtration rate correlate with increased risk of cognitive impairment.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Arciniegas DB, Anderson CA, Filley CM. Structural and functional neuroanatomy executive function. In: Behavioral Neurology and Neuropsychiatry. England: Cambridge University Press; 2013. https://doi.org/10.1017/cbo9781139016919.018

Etgen T. Kidney disease as a determinant of cognitive decline and dementia. Alzheimers Res Ther. 2015;7(1):29. https://doi. org/10.1186/s13195-015-0115-4 PMid:25780391

da Matta SM, Moreira JM, E Kummer AM, Guimarães I, Teixeira AL, E Silva AC. Cognitive alterations in chronic kidney disease: An update. J Bras Nefrol. 2014;36(2):241-5. PMid:25055365

Bronas UG, Puzantian H, Hannan M. Cognitive impairment in chronic kidney disease: Vascular milieu and the potential therapeutic role of exercise. Biomed Res Int. 2017;2017:2726369. https://doi.org/10.1155/2017/2726369 PMid:28503567

Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G, Massy ZA. Cognitive disorders and dementia in CKD: The neglected kidney-brain axis. J Am Soc Nephrol. 2013;24(3):353- 63. https://doi.org/10.1681/asn.2012050536 PMid:23291474

Buchman AS, Tanne D, Boyle PA, Shah RC, Leurgans SE, Bennett DA. Kidney function is associated with the rate of cognitive decline in the elderly. Neurology. 2009;73(12):920-7. https://doi.org/10.1212/wnl.0b013e3181b72629 PMid:19657107

Kurella M, Chertow GM, Luan J, Yaffe K. Cognitive impairment in chronic kidney disease. J Am Geriatr Soc. 2004;52(11):1863- 9. https://doi.org/10.1111/j.1532-5415.2004.52508.x PMid:15507063

Helmer C, Stengel B, Metzger M, Froissart M, Massy ZA, Tzourio C, et al. Chronic kidney disease, cognitive decline, and incident dementia: The 3C Study. Neurology. 2011;77(23):2043- 51. https://doi.org/10.1212/wnl.0b013e31823b4765 PMid:22116945

De Deyn PP, Vanholder R, Eloot S, Glorieux G. Progress in uremic toxin research: Guanidino compounds as uremic (neuro) toxins. In: Seminars in Dialysis. United States: Wiley; 2009. p. 340-5. https://doi.org/10.1111/j.1525-139x.2009.00577.x

Patel M, Dasgupta I, Tadros G, Baharani J. Cognitive impairment in hemodialysis patients: What can slow this decline? Hong Kong J Nephrol. 2016;18:4-10. https://doi.org/10.1016/j. hkjn.2015.08.003

Kurella M, Mapes DL, Port FK, Chertow GM. Correlates and outcomes of dementia among dialysis patients: The dialysis outcomes and practice patterns study. Nephrol Dial Transplant. 2006;21(9):2543-8. https://doi.org/10.1093/ndt/gfl275 PMid:16751655

Grimm G, Stockenhuber F, Schneeweiss B, Madl C, Zeitlhofer J, Schneider B. Improvement of brain function in hemodialysis patients treated with erythropoietin. Kidney Int. 1990;38(3):480-6. https://doi.org/10.1038/ki.1990.229 PMid:2232491

Iadecola C, Yaffe K, Biller J, Bratzke LC, Faraci FM, Gorelick PB, et al. Impact of hypertension on cognitive function: A scientific statement from the American heart association. Hypertension. 2016;68(6):e67-94. https://doi.org/10.1161/ hyp.0000000000000053

Pase MP, Beiser A, Himali JJ, Tsao C, Satizabal CL, Vasan RS, et al. Aortic stiffness and the risk of incident mild cognitive impairment and dementia. Stroke. 2016;47(9):2256-61. https:// doi.org/10.1161/strokeaha.116.013508 PMid:27491735

Khatri M, Nickolas T, Moon YP, Paik MC, Rundek T, Elkind MS, et al. CKD associates with cognitive decline. J Am Soc Nephrol. 2009;20(11):2427-32. https://doi.org/10.1681/asn.2008101090 PMid:19729443

Spauwen PJ, Köhler S, Verhey FR, Stehouwer CD, van Boxtel MP. Effects of Type 2 diabetes on 12-year cognitive change: Results from the Maastricht aging study. Diabetes Care. 2013;36(6):1554-61. https://doi.org/10.2337/dc12-0746 PMid:23275366

Roberts R, Knopman DS. Classification and epidemiology of MCI. Clin Geriatr Med. 2013;29(4):753-72. PMid:24094295

MacKnight C, Rockwood K, Awalt E, McDowell I. Diabetes mellitus and the risk of dementia, Alzheimer’s disease and vascular cognitive impairment in the Canadian study of health and aging. Dement Geriatr Cogn Disord. 2002;14(2):77-83. https://doi.org/10.1159/000064928 PMid:12145454

de Andrade Paraizo M, Almeida AL, Pires LA, Abrita RS, Crivellari MH, Dos Santos Pereira B, et al. Montreal cognitive assessment (MoCA) screening mild cognitive impairment in patients with chronic kidney disease (CKD) pre-dialysis. Braz J Nephrol. 2016;38(1):31-41. https://doi. org/10.5935/0101-2800.20160006 PMid:27049362

Hong CH, Falvey C, Harris TB, Simonsick EM, Satterfield S, Ferrucci L, et al. Anemia and risk of dementia in older adults: Findings from the health ABC study. Neurology. 2013;81(6):528- 33. https://doi.org/10.1212/wnl.0b013e31829e701d PMid:23902706

Antunes JP, Bulhões C, Fonte P, Abreu MJ, Oliveira R. Renal function and cognitive dysfunction: Cross-sectional study of users enrolled at ponte-family health unit. Braz J Nephrol. 2015;37(1):79-90. https://doi.org/10.5935/0101-2800.20150012

Atkinson HH, Cesari M, Kritchevsky SB, Penninx BW, Fried LP, Guralnik JM, et al. Predictors of combined cognitive and physical decline. J Am Geriatr Soc. 2005;53(7):1197-202. https://doi. org/10.1111/j.1532-5415.2005.53362.x PMid:16108938

Shah RC, Buchman AS, Wilson RS, Leurgans SE, Bennett DA. Hemoglobin level in older persons and incident Alzheimer disease: Prospective cohort analysis. Neurology. 2011;77(3):219- 26. https://doi.org/10.1212/wnl.0b013e318225aaa9 PMid:21753176